Replies to post #150 on Esperion Therapeutics Inc (ESPR)

[BuckeyeMike]

Glad I backed up the truck on Friday. :-D

Stock traded 100+ previously prior to FDA requiring CVOT. Now with Clear path to Approval, could get past $100 again. Investors also have to wonder if someone like AMGN, MRK, or ? would jump in and buy Esperion and their renown team of Lipid Experts.

Big Short Position also caught in today's squeeze. Traded 106,000 shares after hours and I think ended around $41.60 up 30cents.

$ESPR' bempedoic acid:
Orally active
lowers LDL & hsCRP - helps reduce inflammation
clean safety profile
will b a lot CHEAPER than PCSK9i drugs

Do your own DD & GL!